Navigation Links
BIA Publishes White Paper: ISO 9000 Role in Document Review, Emphasizes 'Quality Equals Defensibility'
Date:10/2/2009

NEW YORK, Oct. 2 /PRNewswire/ -- Business Intelligence Associates, Inc. (BIA), an information management industry leader, today released "The Role of ISO 9000 in Document Review". This white paper highlights BIA's recent ISO 9001:2008 certification for its Document Review Services' Quality Management System.

BIA's white paper identifies difficulties and solutions in developing a document review Quality Management System (QMS), where human-based services depend on the professional judgment of attorney reviewers. Part of its solution is its ISO 9000 certification, which assures clients of operational ISO QMS standards.

"BIA's Document Review Services are independent of any single review tool or platform," states Adam Feinberg, BIA's Director of Quality Assurance. "With our ISO 9001:2008 certified process-based approach, we reduce overall review project time with error-checking methods - thereby controlling client costs - regardless of the review platform used."

Feinberg adds, "BIA spent over a year ensuring that there is a documented, process-based approach provided to all Document Review Services clients. The use of existing ISO 9000 Quality standards means that BIA's document review services can be defended to the courts whenever necessary. BIA's assertion - that quality equals defensibility - is critical to defensible solutions."

BIA's white paper highlights several pertinent items, including BIA's accuracy hybrid-database that identifies patterns and errors; "process-driven" document reviews and outcomes; and issues facing "agencies'" hiring of part-time attorneys.

BIA's white paper may be downloaded: http://www.biaprotect.com/sept-2009-white-paper

About BIA

Since 2002, BIA has been dedicated to the development and implementation of defensible, technology-driven solutions that reduce the costs and risks associated with the management and analysis of digital evidence and critical corporate data. BIA offers a wide range of services including Preservation & Collection, Processing & Analytics, Digital Investigations, Commercial Fraud Investigations & Analysis, Electronic Policy Consulting, Audit/Certification Services, HR Data Related Policy, Disaster Recovery, and Legal Document Review. Clients include Fortune 100, Global 2000 and Legal 500 companies, and government agencies. Headquartered in New York City, BIA has additional offices in San Francisco, Washington, DC, and a central processing center in Southwest Michigan. BIA maintains digital evidence response units throughout the United States, Europe, Asia, and the Middle East. BIA's unique and positive workplace culture promotes diversity and celebrates the professional skills of each individual.

For more information about BIA, please visit www.biaprotect.com.

For additional information, contact Erin K. Smith: 888.338.4242 or esmith@biaprotect.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Adam Hurwitz

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=85257

Alon Israely

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81510

Brian Schrader

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81511

Maurice Bortz

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81512

SOURCE Business Intelligence Associates, Inc.


'/>"/>
SOURCE Business Intelligence Associates, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. United States Patent and Trademark Office Publishes Stemedicas Patent Application for the Treatment of Diabetic Retinopathy
2. The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide
3. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
4. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
5. Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinsons Disease
6. New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
7. Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
8. American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation
9. New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients
10. Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent
11. The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... YORK , Jan. 23, 2017 ... detect, and control light. The interaction of these ... used in a wide range of applications. These ... aerospace and defense, telecommunications, and healthcare among others. ... primarily owing to its low power consumption, reliability, ...
(Date:1/24/2017)... VALLEY COTTAGE, New York , January 23, 2017 ... Projected to Witness Sluggish Growth ... world are derived from formulating Active Pharmaceutical Ingredients (API), ... isopropanol, propanol and propylene glycol. Production of ... Asia-Pacific excluding Japan ...
(Date:1/23/2017)... 2017  Therabron Therapeutics, Inc., a clinical-stage biotechnology ... respiratory care, today announced that the European Medicines ... granted Orphan Drug Designation for Therabron,s CG367 program, ... (BOS).  "We are pleased to have ... treat patients diagnosed with BOS following lung transplantation. ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 23, 2017 , ... The Pharmacy and Medically Underserved ... bipartisan original co-sponsorship of nearly one-quarter of the U.S. House of Representatives. The ... Chain Drug Stores (NACDS) strongly backs the legislation. , “NACDS thanks for their ...
(Date:1/24/2017)... ... 23, 2017 , ... The TouchPoint Solution, parent company of ... into the product’s app. The data replicates and validates Co-Founder and Neuropsychologist ... 30 seconds of using Buzzies, people experienced a 74 percent reduction in their ...
(Date:1/23/2017)... York, NY (PRWEB) , ... January 23, 2017 , ... ... announced today that John J. Nelson, a senior accountant at the Firm, will participate ... of Make-A-Wish® Hudson Valley. Over 200 runners will race up 1,576 steps, a vertical ...
(Date:1/23/2017)... FL (PRWEB) , ... January 23, 2017 , ... Wooden and plastic balance boards have ... strength and improve balance. Kumo Board is the first and only balance board ... it to be soft and rigid at the same time as well as skill-level adjustable ...
(Date:1/23/2017)... ... 2017 , ... METTLER TOLEDO has announced the availability of ... PAT Tools . , Crystallization is a common step used during ... Chemists now spend more time developing better intermediate and final crystallization steps. ...
Breaking Medicine News(10 mins):